PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Sleep discovery could lead to therapies that improve memory

UC Riverside psychologist's research team discovers sleep mechanism critical to memory consolidation and finds that Ambien enhances the process

Sleep discovery could lead to therapies that improve memory
2013-03-12
(Press-News.org) RIVERSIDE, Calif. — A team of sleep researchers led by UC Riverside psychologist Sara C. Mednick has confirmed the mechanism that enables the brain to consolidate memory and found that a commonly prescribed sleep aid enhances the process. Those discoveries could lead to new sleep therapies that will improve memory for aging adults and those with dementia, Alzheimer's and schizophrenia.

The groundbreaking research appears in a paper, "The Critical Role of Sleep Spindles in Hippocampal-Dependent Memory: A Pharmacology Study," published in the Journal of Neuroscience.

Earlier research found a correlation between sleep spindles — bursts of brain activity that last for a second or less during a specific stage of sleep — and consolidation of memories that depend on the hippocampus. The hippocampus, part of the cerebral cortex, is important in the consolidation of information from short-term to long-term memory, and spatial navigation. The hippocampus is one of the first regions of the brain damaged by Alzheimer's disease.

Mednick and her research team demonstrated, for the first time, the critical role that sleep spindles play in consolidating memory in the hippocampus, and they showed that pharmaceuticals could significantly improve that process, far more than sleep alone.

In addition to Mednick the research team includes: Elizabeth A. McDevitt, UC San Diego; James K. Walsh, VA San Diego Healthcare System, La Jolla, Calif; Erin Wamsley, St. Luke's Hospital, St. Louis, Mo.; Martin Paulus, Stanford University; Jennifer C. Kanady, Harvard Medical School; and Sean P.A. Drummond, UC Berkeley.

"We found that a very common sleep drug can be used to increase verbal memory," said Mednick, the lead author of the paper that outlines results of two studies conducted over five years with a $651,999 research grant from the National Institutes of Health. "This is the first study to show you can manipulate sleep to improve memory. It suggests sleep drugs could be a powerful tool to tailor sleep to particular memory disorders."

A total of 49 men and women between the ages of 18 and 39 who were normal sleepers were given varying doses of zolpidem (Ambien) or sodium oxybate (Xyrem), and a placebo, allowing several days between doses to allow the pharmaceuticals to leave their bodies. Researchers monitored their sleep, measured sleepiness and mood after napping, and used several tests to evaluate their memory.

The researchers found that zolpidem significantly increased the density of sleep spindles and improved verbal memory consolidation.

"(P)harmacologically enhancing sleep spindles in healthy adults produces exceptional memory performance beyond that seen with sleep alone or sleep with the comparison drug (sodium oxybate)," the sleep researchers wrote. "… The results set the stage for targeted treatment of memory impairments as well as the possibility of exceptional memory improvement above that of a normal sleep period."

Mednick said one of the next steps in this line of research is to determine which component of the physical response to Ambien — the amnesia associated with the drug, or something related to a specific aspect of sleep — is responsible for increasing the density of sleep spindles and the resulting consolidation of memory. She also hopes to study the impact of zolpidem on older adults, who experience poor declarative memory and also decreased sleep spindles. Individuals with Alzheimer's, dementia and schizophrenia also experience decreases in sleep spindles.

"Could we find a dose response, for example, the more Ambien, the more benefit?" she asked.

Sleep is a very new field of research and its importance is generally not taught in medical schools, Mednick said.

"We know very little about it," said Mednick, who began studying sleep in the early 2000s with research into how naps benefit perceptual learning. "We do know that it affects behavior, and we know that sleep is integral to a lot of disorders with memory problems. We need to integrate sleep into medical diagnoses and treatment strategies. This research opens up a lot of possibilities."

INFORMATION:

[Attachments] See images for this press release:
Sleep discovery could lead to therapies that improve memory

ELSE PRESS RELEASES FROM THIS DATE:

Off-pump bypass better for high-risk patients

2013-03-12
SAN FRANCISCO (March 11, 2013) — Bypass surgery done without a heart-lung machine, known as off-pump, may provide better post-operative outcomes than on-pump bypass surgery for high-risk patients, according to research presented today at the American College of Cardiology's 62nd Annual Scientific Session. In the first study to look specifically at on-pump versus off-pump bypass surgery among patients deemed to be at high operative risk, researchers examined the primary endpoint of patients' combined outcomes of all-cause death, stroke, heart attack or renal failure requiring ...

Exercise during gestation might affect future fertility

2013-03-12
Des Moines, IA - A short walk around the barn might improve the future fertility of Yorkshire gilts. According to research presented by Samantha Kaminski, a graduate student at North Dakota State University, swine fetuses showed significant ovarian development after their mothers exercised. Kaminski and fellow researchers already knew that uterine blood flow could affect blood flow to the ovaries of developing fetuses. To further study the relationship between uterine blood flow and ovary development, Kaminski and fellow researchers designed an experiment to increase ...

Children who avoid scary situations likelier to have anxiety, Mayo Clinic research finds

2013-03-12
ROCHESTER, Minn. -- Children who avoid situations they find scary are likely to have anxiety a Mayo Clinic study of more than 800 children ages 7 to 18 found. The study published this month in Behavior Therapy presents a new method of measuring avoidance behavior in young children. The researchers developed two eight-question surveys: the Children's Avoidance Measure Parent Report and the Children's Avoidance Measure Self Report. The questionnaires ask details about children's avoidance tendencies, for instance, in addressing parents, "When your child is scared or worried ...

Logging debris gives newly planted Douglas-fir forests a leg-up

2013-03-12
The downed limbs and other woody debris that are inevitable byproducts of timber harvest could be among the most important components of post-harvest landscapes, according to a new study led by the U.S. Forest Service's Pacific Northwest Research Station. Researchers found that retaining moderate levels of logging debris, also known as "slash," helped to both directly and indirectly increase the growth rate of Douglas-fir seedlings replanted after harvest. The findings, which are among the first to speak to the benefits of second-growth logging debris, are published ...

Drug may improve outcomes after heart attack

2013-03-12
SAN FRANCISCO (March 10, 2013) — The prescription drug eplerenone appears to reduce the risk of cardiovascular mortality and heart failure after a heart attack by more than one-third, according to research presented today at the American College of Cardiology's 62nd Annual Scientific Session. The REMINDER (Reduction of heart failure morbidity in patients with acute ST-elevation myocardial infarction) trial was a randomized, double-blind trial of 1,012 patients who had a heart attack caused by a complete blockage of one of the heart's arteries. Patients had no signs or ...

Investigational drug reduces heart damage during angioplasty

2013-03-12
SAN FRANCISCO (March 10, 2013) — A single dose of an investigational anti-inflammatory drug, inclacumab, reduced damage to heart tissue during angioplasty in a study presented today at the American College of Cardiology's 62nd Annual Scientific Session. More than 1 million coronary angioplasty procedures are performed in the United States each year, at a cost of more than $10 billion. Heart tissue can be damaged during angioplasty, often leading to additional procedures, poor outcomes and higher health care costs. In this trial, researchers compared a single dose of ...

Clot-busting drug as effective as angioplasty

2013-03-12
SAN FRANCISCO (March 10, 2013) — A clot-busting therapy may benefit some heart attack patients who cannot have immediate angioplasty, according to research presented today at the American College of Cardiology's 62nd Annual Scientific Session. "Drug therapy before transfer is at least as effective as [angioplasty], and an urgent catheterization was avoided in two-thirds of patients," said Frans Van de Werf, MD, PhD, professor of cardiology at University of Leuven, Belgium, and the study's lead investigator. "It gives [clinicians] time to consider other options, such ...

Drug reduces chest pain in patients with diabetes

2013-03-12
SAN FRANCISCO (March 10, 2013) — A commonly used anti-anginal drug reduces chest pain in patients with type 2 diabetes and appears to have a more pronounced effect in those with poorer glucose control, according to research presented today at the American College of Cardiology's 62nd Annual Scientific Session. Ranolazine is approved by the U.S. Food and Drug Administration for the treatment of chronic angina, or chest pain, both as first line therapy and as an add-on when symptoms are not relieved with other anti-anginal drugs, including beta-blockers, calcium channel ...

High-dose oral vitamins, minerals do not reduce recurrent cardiac events in heart attack patients

2013-03-12
SAN FRANCISCO (March 10, 2013) — Heart attack patients given a combination of high-dose oral vitamins and minerals do not exhibit a significant reduction in recurrent cardiac events, according to research presented today at the American College of Cardiology's 62nd Annual Scientific Session. However, the results of one component of the NIH-funded Trial to Assess Chelation Therapy (TACT) study, shows that when combined with active chelation therapy, high-dose vitamins and minerals may provide some additional benefit. The TACT study tested the safety and effectiveness of ...

Digoxin reduces hospital admissions in older patients with chronic heart failure

2013-03-12
SAN FRANCISCO (March 11, 2013) —Digoxin significantly reduces the likelihood of hospital admission due to all causes among ambulatory older patients with chronic heart failure and reduced ejection fraction (HFrEF), according to research presented today at the American College of Cardiology's 62nd Annual Scientific Session. Researchers reviewed patient outcomes from 1995 in the Digitalis Investigation Group (DIG) trial of 6,800 patients with HFrEF—a condition in which the heart is too weak to pump and patients suffer from breathlessness and fatigue. Patients with HFrEF ...

LAST 30 PRESS RELEASES:

The most effective diabetes drugs don't reach enough patients yet

Breast cancer risk in younger women may be influenced by hormone therapy

Strategies for staying smoke-free after rehab

Commentary questions the potential benefit of levothyroxine treatment of mild hypothyroidism during pregnancy

Study projects over 14 million preventable deaths by 2030 if USAID defunding continues

New study reveals 33% gap in transplant access for UK’s poorest children

Dysregulated epigenetic memory in early embryos offers new clues to the inheritance of polycystic ovary syndrome (PCOS)

IVF and IUI pregnancy rates remain stable across Europe, despite an increasing uptake of single embryo transfer

It takes a village: Chimpanzee babies do better when their moms have social connections

From lab to market: how renewable polymers could transform medicine

Striking increase in obesity observed among youth between 2011 and 2023

No evidence that medications trigger microscopic colitis in older adults

NYUAD researchers find link between brain growth and mental health disorders

Aging-related inflammation is not universal across human populations, new study finds

University of Oregon to create national children’s mental health center with $11 million federal grant

Rare achievement: UTA undergrad publishes research

Fact or fiction? The ADHD info dilemma

Genetic ancestry linked to risk of severe dengue

Genomes reveal the Norwegian lemming as one of the youngest mammal species

Early birds get the burn: Monash study finds early bedtimes associated with more physical activity

Groundbreaking analysis provides day-by-day insight into prehistoric plankton’s capacity for change

Southern Ocean saltier, hotter and losing ice fast as decades-long trend unexpectedly reverses

Human fishing reshaped Caribbean reef food webs, 7000-year old exposed fossilized reefs reveal

Killer whales, kind gestures: Orcas offer food to humans in the wild

Hurricane ecology research reveals critical vulnerabilities of coastal ecosystems

Montana State geologist’s Antarctic research focuses on accumulations of rare earth elements

Groundbreaking cancer therapy clinical trial with US Department of Energy’s accelerator-produced actinium-225 set to begin this summer

Tens of thousands of heart attacks and strokes could be avoided each year if cholesterol-lowering drugs were used according to guidelines

Leading cancer and metabolic disease expert Michael Karin joins Sanford Burnham Prebys

Low-intensity brain stimulation may restore neuron health in Alzheimer's disease

[Press-News.org] Sleep discovery could lead to therapies that improve memory
UC Riverside psychologist's research team discovers sleep mechanism critical to memory consolidation and finds that Ambien enhances the process